{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:11:29Z","timestamp":1789038689398,"version":"build-2803163510"},"reference-count":69,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH\/NIAID","award":["5R01AI66573"],"award-info":[{"award-number":["5R01AI66573"]}]},{"name":"Tufts Launchpad\u2502Accelerator Program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background: The continued emergence of antimicrobial-resistant Neisseria gonorrhoeae highlights the urgent need for an effective vaccine. We evaluated the immunogenicity and vaccine potential of six new gonococcal conserved hypothetical proteins identified through our immunobioinformatics-based pipeline (Candidate Antigen Selection Strategy, CASS). Methods: NGO0588, NGO0694, NGO0757, NGO0861, NGO1438 and NGO1802 proteins were expressed in E. coli, purified, and used to immunize mice, adjuvanted with Alum and MPLA. Immunological analyses included quantitative and qualitative evaluation of antigen-specific antibody responses, cytokines, serum bactericidal activity (SBA), and protective efficacy in the mouse gonococcal vaginal colonization model. Results: The six antigens elicited robust antigen-specific IgG and IgM antibody responses against N. gonorrhoeae. Antisera to NGO0588, NGO0861, NGO1430 and NGO1802 were bactericidal against different gonococcal strains. IgG antibodies recognizing the antigens were detected in sera obtained from women with disseminated gonococcal infection, particularly against NGO1802, supporting immunogenicity in humans. Taking immunological and biochemical properties into consideration, NGO0861, NGO1438 and NGO1802 were combined in a trivalent vaccine formulation. The trivalent vaccine elicited robust antigen-specific and N. gonorrhoeae-reactive serum IgG and IgM, mucosal IgG, and higher SBA titers than each individual antigen. However, in the mouse gonococcal vaginal colonization model, vaccinated mice and adjuvant control mice did not show statistically significant differences in time to infection clearance or bacterial burdens. Conclusions: A multiantigen vaccine composed of NGO0861, NGO1438 and NGO1802 elicited antibodies that were functional in vitro but did not lead to protection in vivo. Immunological analyses in vitro and in vivo emphasize the importance of evaluating antigen and antibody quality and functional activity for vaccine target prioritization of next-generation gonococcal multicomponent vaccines.<\/jats:p>","DOI":"10.3390\/vaccines14090798","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:27:21Z","timestamp":1789036041000},"page":"798","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preclinical Evaluation of Novel Conserved Neisseria gonorrhoeae Vaccine Candidates Identified Through Infection-Informed Antigen Discovery"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3163-7397","authenticated-orcid":false,"given":"Shea K.","family":"Roe","sequence":"first","affiliation":[{"name":"Department of Immunology, Tufts University School of Medicine, Boston, MA 02111, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"}]},{"given":"Bo","family":"Zheng","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Immunology, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Sunita","family":"Gulati","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Immunology, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Sanjay","family":"Ram","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Immunology, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3106-0711","authenticated-orcid":false,"given":"Paola","family":"Massari","sequence":"additional","affiliation":[{"name":"Department of Immunology, Tufts University School of Medicine, Boston, MA 02111, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2026, August 08). Global and Regional STI Estimates. Available online: https:\/\/www.who.int\/data\/gho\/data\/themes\/topics\/global-and-regional-sti-estimates."},{"key":"ref_2","unstructured":"Centers for Disease Control and Prevention (2026, July 26). Sexually Transmitted Infections Surveillance 2024 (Provisional), Available online: https:\/\/www.cdc.gov\/sti-statistics\/annual\/index.html#cdc_research_or_data_summary_about_the_data_research-technical-notes."},{"key":"ref_3","unstructured":"Centers for Disease Control and Prevention (2026, August 08). Sexually Transmitted Disease Surveillance 2023, Available online: https:\/\/www.cdc.gov\/sti-statistics\/annual\/index.html."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Unemo, M., Del Rio, C., and Shafer, W.M. (2016). Antimicrobial Resistance Expressed by Neisseria gonorrhoeae: A Major Global Public Health Problem in the 21st Century. Microbiol. Spectr., 4.","DOI":"10.1128\/microbiolspec.EI10-0009-2015"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"101181","DOI":"10.1016\/j.lanmic.2025.101181","article-title":"WHO global gonococcal antimicrobial surveillance programmes, 2019\u20132022: A retrospective observational study","volume":"6","author":"Unemo","year":"2025","journal-title":"Lancet Microbe"},{"key":"ref_6","unstructured":"World Health Organization (2026, July 26). Implementing the Global Health Sector Strategies on HIV, Viral Hepatitis and Sexually Transmitted Infections, 2022\u20132030: Report on Progress and Gaps 2024, Second Edition. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240097872."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e1544","DOI":"10.1016\/S2214-109X(24)00266-3","article-title":"WHO global research priorities for sexually transmitted infections","volume":"12","author":"Gottlieb","year":"2024","journal-title":"Lancet Glob. Health"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Russell, M.W., Jerse, A.E., and Gray-Owen, S.D. (2019). Progress Toward a Gonococcal Vaccine: The Way Forward. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.02417"},{"key":"ref_9","first-page":"e758","article-title":"Urgent Need to Understand and Prevent Gonococcal Infection: From the Laboratory to Real-World Context","volume":"230","author":"Marrazzo","year":"2024","journal-title":"J. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e0010724","DOI":"10.1128\/cmr.00107-24","article-title":"Biologic drug development for treatment and prevention of sexually transmitted infections","volume":"38","author":"Gill","year":"2025","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.vaccine.2024.03.068","article-title":"Review of mathematical models of Neisseria gonorrhoeae vaccine impact: Implications for vaccine development","volume":"42","author":"Padeniya","year":"2024","journal-title":"Vaccine"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/infdis\/jiae383","article-title":"Effectiveness of MenB-4C Vaccine Against Gonorrhea: A Systematic Review and Meta-analysis","volume":"231","author":"Abara","year":"2025","journal-title":"J. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2357924","DOI":"10.1080\/21645515.2024.2357924","article-title":"4CMenB journey to the 10-year anniversary and beyond","volume":"20","author":"Abitbol","year":"2024","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(17)31449-6","article-title":"Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: A retrospective case-control study","volume":"390","author":"Paynter","year":"2017","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Paynter, J., Goodyear-Smith, F., Morgan, J., Saxton, P., Black, S., and Petousis-Harris, H. (2019). Effectiveness of a Group B Outer Membrane Vesicle Meningococcal Vaccine in Preventing Hospitalization from Gonorrhea in New Zealand: A Retrospective Cohort Study. Vaccines, 7.","DOI":"10.3390\/vaccines7010005"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"126312","DOI":"10.1016\/j.vaccine.2024.126312","article-title":"Effectiveness of a serogroup B meningococcal vaccine against gonorrhea: A retrospective study","volume":"42","author":"Abara","year":"2024","journal-title":"Vaccine"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e1341","DOI":"10.1093\/cid\/ciac436","article-title":"Prevention of Neisseria gonorrhoeae With Meningococcal B Vaccine: A Matched Cohort Study in Southern California","volume":"76","author":"Bruxvoort","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/cid\/ciy1061","article-title":"The serogroup B meningococcal vaccine Bexsero elicits antibodies to Neisseria gonorrhoeae","volume":"69","author":"Semchenko","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Leduc, I., Connolly, K.L., Begum, A., Underwood, K., Darnell, S., Shafer, W.M., Balthazar, J.T., Macintyre, A.N., Sempowski, G.D., and Duncan, J.A. (2020). The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae. PLoS Pathog., 16.","DOI":"10.1101\/2020.05.13.094177"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Zhu, W., Waltmann, A., Little, M.B., Connolly, K.L., Matthias, K.A., Thomas, K.S., Gray, M.C., Sikora, A.E., Criss, A.K., and Bash, M.C. (2025). Protection against N. gonorrhoeae induced by OMV-based meningococcal vaccines are associated with cross-species directed humoral and cellular immune responses. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1539795"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S1473-3099(24)00236-6","article-title":"Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): A multicentre, open-label, randomised trial with a 2 \u00d7 2 factorial design","volume":"24","author":"Molina","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJMoa2516739","article-title":"Meningococcal B Vaccine to Prevent Neisseria gonorrhoeae Infection","volume":"395","author":"Seib","year":"2026","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e0038822","DOI":"10.1128\/msphere.00388-22","article-title":"Microencapsulated IL-12 Drives Genital Tract Immune Responses to Intranasal Gonococcal Outer Membrane Vesicle Vaccine and Induces Resistance to Vaginal Infection with Diverse Strains of Neisseria gonorrhoeae","volume":"8","author":"Liu","year":"2023","journal-title":"mSphere"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41541-026-01491-z","article-title":"Pre-clinical efficacy of a candidate outer membrane vesicle gonococcal vaccine in comparison with 4CMenB","volume":"11","author":"Freixeiro","year":"2026","journal-title":"npj Vaccines"},{"key":"ref_25","unstructured":"(2026, July 27). Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healthy Adults 18 to 50 Years of Age, Available online: https:\/\/clinicaltrials.gov\/study\/NCT05630859?tab=results#results-overview."},{"key":"ref_26","unstructured":"Taylor, N.P. (2026, June 25). GSK Axes Vaccine from $2.1B Deal, Switching to Preclinical Successor Over \u2018Increased Competition\u2019. Available online: https:\/\/www.fiercebiotech.com\/biotech\/gsk-axes-vaccine-21b-deal-switching-preclinical-successor-over-increased-competition."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e100281","DOI":"10.1136\/bmj-2026-100281","article-title":"Gonorrhoea vaccine: Australian study suggests England\u2019s \u201cworld first\u201d rollout may not work","volume":"394","author":"Taylor","year":"2026","journal-title":"BMJ"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e0009423","DOI":"10.1128\/cmr.00094-23","article-title":"Neisseria gonorrhoeae vaccines: A contemporary overview","volume":"37","author":"Williams","year":"2024","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Gulati, S., Shaughnessy, J., Ram, S., and Rice, P.A. (2019). Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00321"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e0250023","DOI":"10.1128\/mbio.02500-23","article-title":"Preclinical efficacy of a cell division protein candidate gonococcal vaccine identified by artificial intelligence","volume":"14","author":"Gulati","year":"2023","journal-title":"mBio"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Fegan, J.E., Calmettes, C., Islam, E.A., Ahn, S.K., Chaudhuri, S., Yu, R.H., Gray-Owen, S.D., Moraes, T.F., and Schryvers, A.B. (2019). Utility of Hybrid Transferrin Binding Protein Antigens for Protection Against Pathogenic Neisseria Species. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00247"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"126416","DOI":"10.1016\/j.vaccine.2024.126416","article-title":"Refinement and optimisation of Neisseria gonorrhoeae NHBA and MetQ vaccine candidates","volume":"42","author":"Taha","year":"2024","journal-title":"Vaccine"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.vaccine.2013.12.070","article-title":"Immuno-proteomic analysis of human immune responses to experimental Neisseria meningitidis outer membrane vesicle vaccines identifies potential cross-reactive antigens","volume":"32","author":"Williams","year":"2014","journal-title":"Vaccine"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"McClure, R., Nudel, K., Massari, P., Tjaden, B., Su, X., Rice, P.A., and Genco, C.A. (2015). The Gonococcal Transcriptome during Infection of the Lower Genital Tract in Women. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0133982"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"McClure, R., Sunkavalli, A., Balzano, P.M., Massari, P., Cho, C., Nauseef, W.M., Apicella, M.A., and Genco, C.A. (2020). Global Network Analysis of Neisseria gonorrhoeae Identifies Coordination between Pathways, Processes, and Regulators Expressed during Human Infection. mSystems, 5.","DOI":"10.1128\/msystems.00729-19"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Zhu, T., McClure, R., Harrison, O.B., Genco, C., and Massari, P. (2019). Integrated Bioinformatic Analyses and Immune Characterization of New Neisseria gonorrhoeae Vaccine Antigens Expressed during Natural Mucosal Infection. Vaccines, 7.","DOI":"10.3390\/vaccines7040153"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Roe, S.K., Felter, B., Zheng, B., Ram, S., Wetzler, L.M., Garges, E., Zhu, T., Genco, C.A., and Massari, P. (2023). In Vitro Pre-Clinical Evaluation of a Gonococcal Trivalent Candidate Vaccine Identified by Transcriptomics. Vaccines, 11.","DOI":"10.3390\/vaccines11121846"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Roe, S.K., Zheng, B., Gulati, S., Genco, C., Ram, S., and Massari, P. (2025). Preclinical in vivo evaluation of a gonococcal multivalent vaccine containing antigens identified by CASS. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1688536"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Roe, S.K., Mazgaj, R., Zhu, T., Esmaeeli, M., Lewis, L.A., Genco, C., Waldron, K.J., and Massari, P. (2025). The gonococcal vaccine candidate antigen NGO1701 is a N. gonorrhoeae periplasmic copper storage protein. PLoS Pathog., 21.","DOI":"10.1101\/2025.05.01.651437"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"124","DOI":"10.12688\/wellcomeopenres.14826.1","article-title":"Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications","volume":"3","author":"Jolley","year":"2018","journal-title":"Wellcome Open Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"D368","DOI":"10.1093\/nar\/gkad1011","article-title":"AlphaFold Protein Structure Database in 2024: Providing structure coverage for over 214 million protein sequences","volume":"52","author":"Varadi","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"ref_44","unstructured":"(2026, May 07). The PyMOL Molecular Graphics System, Version 3.0 Schr\u00f6dinger, LLC. Available online: http:\/\/www.pymol.org\/pymol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00005792-198311000-00005","article-title":"Disseminated Gonococcal Infection: A Prospective Analysis of 49 Patients and a Review of the Pathophysiology and Immune Mechanisms","volume":"62","author":"Goldenberg","year":"1983","journal-title":"Medicine"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1128\/IAI.67.11.5699-5708.1999","article-title":"Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice","volume":"67","author":"Jerse","year":"1999","journal-title":"Infect. Immun."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1128\/JB.00839-13","article-title":"Control of RNA stability by NrrF, an iron-regulated small RNA in Neisseria gonorrhoeae","volume":"195","author":"Jackson","year":"2013","journal-title":"J. Bacteriol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Marjuki, H., Topaz, N., Joseph, S.J., Gernert, K.M., Kersh, E.N., Antimicrobial-Resistant Neisseria gonorrhoeae Working Group, and Wang, X. (2019). Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine. mBio, 10.","DOI":"10.1128\/mBio.01668-19"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1574-6976.2006.00013.x","article-title":"Protein secretion and secreted proteins in pathogenic Neisseriaceae","volume":"30","author":"Tommassen","year":"2006","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Isabella, V.M., and Clark, V.L. (2011). Deep sequencing-based analysis of the anaerobic stimulon in Neisseria gonorrhoeae. BMC. Genom., 12.","DOI":"10.1186\/1471-2164-12-51"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1074\/mcp.M113.029538","article-title":"Quantitative proteomics of the Neisseria gonorrhoeae cell envelope and membrane vesicles for the discovery of potential therapeutic targets","volume":"13","author":"Zielke","year":"2014","journal-title":"Mol. Cell Proteom."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1080\/21645515.2017.1356961","article-title":"A deeper mining on the protein composition of VA-MENGOC-BC\u00ae: An OMV-based vaccine against N. meningitidis serogroup B and C","volume":"13","author":"Masforrol","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41541-023-00651-9","article-title":"OpcA and PorB are novel bactericidal antigens of the 4CMenB vaccine in mice and humans","volume":"8","author":"Viviani","year":"2023","journal-title":"npj Vaccines"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1128\/IAI.67.8.3937-3946.1999","article-title":"Limited local and systemic antibody responses to Neisseria gonorrhoeae during uncomplicated genital infections","volume":"67","author":"Hedges","year":"1999","journal-title":"Infect. Immun."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1128\/iai.43.2.706-709.1984","article-title":"Analysis of the Antigen Specificity of the Human Serum Immunoglobulin GG Immune Response to Complicated Gonococcal Infection","volume":"43","author":"Hook","year":"1984","journal-title":"Infect. Immun."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/infdis\/155.6.1276","article-title":"Evidence of serum antibodies to Neisseria gonorrhoeae before gonococcal infection","volume":"155","author":"Hicks","year":"1987","journal-title":"J. Infect. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Dijokaite-Guraliuc, A., Humbert, M.V., Skipp, P., Cleary, D.W., Heckels, J.E., and Christodoulides, M. (2023). An immunoproteomics study of antisera from patients with gonorrhea identifies novel Neisseria gonorrhoeae proteins. Front. Bacteriol., 2.","DOI":"10.3389\/fbrio.2023.1240807"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1128\/IAI.00714-09","article-title":"A periplasmic thioredoxin-like protein plays a role in defense against oxidative stress in Neisseria gonorrhoeae","volume":"77","author":"Achard","year":"2009","journal-title":"Infect. Immun."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Bodoev, I., Malakhova, M., Bespyatykh, J., Bespiatykh, D., Arapidi, G., Pobeguts, O., Zgoda, V., Shitikov, E., and Ilina, E. (2021). Substitutions in SurA and BamA Lead to Reduced Susceptibility to Broad Range Antibiotics in Gonococci. Genes, 12.","DOI":"10.3390\/genes12091312"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1128\/JB.00532-10","article-title":"Role of the periplasmic chaperones Skp, SurA, and DegQ in outer membrane protein biogenesis in Neisseria meningitidis","volume":"193","author":"Volokhina","year":"2011","journal-title":"J. Bacteriol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"128694","DOI":"10.1016\/j.vaccine.2026.128694","article-title":"Consultation report\u2014Gonococcal immunoassays and standards for vaccine development","volume":"86","author":"MacLennan","year":"2026","journal-title":"Vaccine"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e1443","DOI":"10.1093\/infdis\/jiag216","article-title":"Investigation of Correlates of Protection Against Gonococcal Infection by Comparative Immunoprofiling of Responses in Experimental and Clinical Studies","volume":"233","author":"McKeand","year":"2026","journal-title":"J. Infect. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Gulati, S., Beurskens, F.J., de Kreuk, B.J., Roza, M., Zheng, B., DeOliveira, R.B., Shaughnessy, J., Nowak, N.A., Taylor, R.P., and Botto, M. (2019). Complement alone drives efficacy of a chimeric antigonococcal monoclonal antibody. PLoS Biol., 17.","DOI":"10.1371\/journal.pbio.3000323"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41541-026-01412-0","article-title":"MtrE Loop2-specific multiple antigenic peptide vaccine and monoclonal antibody confer complement-dependent protection against Neisseria gonorrhoeae","volume":"11","author":"Song","year":"2026","journal-title":"npj Vaccines"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"128625","DOI":"10.1016\/j.vaccine.2026.128625","article-title":"MlaA, a conserved outer membrane protein of Neisseria gonorrhoeae, elicits potent functional immunity and protects against vaginal infection as a mucosal vaccine candidate","volume":"82","author":"Lu","year":"2026","journal-title":"Vaccine"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41541-024-01054-0","article-title":"Rational selection of TbpB variants yields a bivalent vaccine with broad coverage against Neisseria gonorrhoeae","volume":"10","author":"Fegan","year":"2025","journal-title":"npj Vaccines"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e0094024","DOI":"10.1128\/msphere.00940-24","article-title":"Meningococcal vaccine 4CMenB elicits a robust cellular immune response that targets but is not consistently protective against Neisseria gonorrhoeae during murine vaginal infection","volume":"10","author":"Zeppa","year":"2025","journal-title":"mSphere"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"126709","DOI":"10.1016\/j.vaccine.2025.126709","article-title":"Adjuvant-dependent impacts on vaccine-induced humoral responses and protection in preclinical models of nasal and genital colonization by pathogenic Neisseria","volume":"48","author":"Islam","year":"2025","journal-title":"Vaccine"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/infdis\/jiv024","article-title":"Antibody to reduction modifiable protein increases the bacterial burden and the duration of gonococcal infection in a mouse model","volume":"212","author":"Gulati","year":"2015","journal-title":"J. Infect. Dis."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/9\/798\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:45:51Z","timestamp":1789037151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/9\/798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":69,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["vaccines14090798"],"URL":"https:\/\/doi.org\/10.3390\/vaccines14090798","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}